."We are starting FY21 with a strong capital position offering significant financial and strategic flexibility. On a pro forma basis, we have $320 million in available cash, $420 million in total liquidity and more than two years to refinance the Company’s remaining term debt, leaving us well-equipped to survive an extended period of traveller uncertainty.”
#injohnwetrust
- Forums
- ASX - By Stock
- WEB
- Ann: 2020 Annual Report
Ann: 2020 Annual Report, page-21
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WEB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.21 |
Change
-0.020(0.22%) |
Mkt cap ! $3.618B |
Open | High | Low | Value | Volume |
$9.30 | $9.34 | $9.20 | $4.085M | 441.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 3386 | $9.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.22 | 5334 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 8955 | 9.200 |
17 | 8910 | 9.190 |
12 | 11159 | 9.180 |
9 | 16929 | 9.170 |
7 | 4208 | 9.160 |
Price($) | Vol. | No. |
---|---|---|
9.210 | 4203 | 17 |
9.220 | 7244 | 18 |
9.230 | 7595 | 16 |
9.240 | 18666 | 10 |
9.250 | 17473 | 13 |
Last trade - 14.43pm 15/07/2024 (20 minute delay) ? |
Featured News
WEB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online